RIGEL PHARMACEUTICALS INC insider trading

RIGLNASDAQ

$47.79+0.64 (+1.36% today)

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 6, 2025 to Oct 5, 2026. Price (+65.4%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Unlock quarterly net flow

Key players

RRRaul R. RodriguezCEO, President1.4634%of company
DLDean L. SchornoEVP & Chief Financial Officer0.4441%of company
DADavid A. SantosEVP, Chief Commercial Officer0.3299%of company
RJRaymond J. FureyEVP, GC, CCO & Corp Sec0.2707%of company
ALAlison L. HannahEVP, Chief Medical Officer0.1875%of company
LRLisa RojkjaerEVP, Chief Medical Officer0.182%of company
WHWalter H. MoosDirector0.0989%of company
JWJane WasmanDirector0.0977%of company
GAGregg Anthony LapointeDirector0.0977%of company
KAKamil Ali-JacksonDirector0.0542%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
RIGL	Kamil Ali-JacksonDirector	Open market sell$87.5K	-19.8%	$35.00	$87.5K	Jun 22, 2026	Jun 24, 2026
RIGL	Kamil Ali-JacksonDirector	Open market sell$72.9K	-16.5%	$29.17	$72.9K	May 26, 2026	May 28, 2026

End of history · 2 transactions